Aisthesis Medical key facts
as of Oct 2026- Developer of an artificial intelligence-powered clinical decision-support system designed to predict and prevent critical health risks such as sepsis in acute care environments.
- Aisthesis Medical is valued at approximately $5.2M as of Oct 2026 (last reported valuation).
- It has raised $1.3M; the latest was Accelerator/Incubator in Mar 2026.
- Notable investors include Microsoft for Startups, AWS Startups, Twin Path Ventures, Caelestinus, Barclays Eagle Lab — 16 tracked in total.
- Status: Privately Held (backing).
Aisthesis Medical's last reported valuation, Sep 2025. Nothing priced has surfaced since.
- ·The complete investor list: 16 names
- ·Watch Aisthesis Medical: the Monday email on marks, rounds and moves
Aisthesis Medical funding rounds
No funding rounds for Aisthesis Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Aisthesis Medical
16+Aisthesis Medical valuation
Aisthesis Medical's last reported valuation was $5.2 million in Sep 2025. No priced round, secondary trade or fund mark has surfaced since.
Aisthesis Medical investors
16 investors are on record for Aisthesis Medical, including Microsoft for Startups, AWS Startups, Twin Path Ventures and Caelestinus.
About Aisthesis Medical
Developer of an artificial intelligence-powered clinical decision-support system designed to predict and prevent critical health risks such as sepsis in acute care environments. The company's platform integrates data from wearable devices, bedside monitors, and electronic health records to build digital patient twins, enabling clinicians to receive explainable, guideline-informed insights that support timely and effective interventions.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2022
- Employees
- 8
- Website
- aisthesismed.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.